SNRIs, or serotonin-norepinephrine reuptake inhibitors, are a class of antidepressant that works by boosting two chemical messengers in the brain: serotonin and norepinephrine. They’re prescribed for depression, several anxiety disorders, and certain types of chronic pain. Five SNRIs are currently approved for use in the United States, and they rank among the most commonly prescribed antidepressants overall.
How SNRIs Work in the Brain
Your nerve cells communicate by releasing chemical messengers (neurotransmitters) into the tiny gap between them. Normally, after serotonin or norepinephrine delivers its signal, the sending nerve cell reabsorbs it, a process called reuptake. SNRIs block that recycling step, so more serotonin and norepinephrine stay active in the gap for longer. The receiving nerve cell gets a stronger, more sustained signal.
Serotonin and norepinephrine each play a distinct role. Serotonin is heavily involved in mood regulation, sleep, and emotional stability. Norepinephrine influences alertness, energy, and the body’s stress response. By raising levels of both, SNRIs address a broader range of symptoms than medications that target serotonin alone. The degree to which each chemical is affected depends on the specific SNRI and the dose.
What SNRIs Are Prescribed For
Depression is the primary reason most people are started on an SNRI. All five approved medications carry an indication for major depressive disorder. Beyond depression, specific SNRIs have additional approved uses:
- Generalized anxiety disorder: Both venlafaxine and duloxetine are approved for ongoing, hard-to-control worry and tension.
- Social anxiety disorder and panic disorder: Venlafaxine is approved for both.
- Chronic pain conditions: Duloxetine is approved for fibromyalgia pain, diabetic nerve pain, and chronic musculoskeletal pain. Milnacipran is approved specifically for fibromyalgia.
The pain-relieving effect comes from a separate mechanism. Serotonin and norepinephrine also operate in pathways that run down through the spinal cord, where they dampen incoming pain signals before those signals reach the brain. When an SNRI increases the activity of these descending pain pathways, it essentially turns up the volume on the body’s built-in pain suppression system. This is why SNRIs can help with physical pain even when depression isn’t part of the picture.
Available SNRI Medications
Five SNRIs are approved in the United States. Each has a slightly different profile in terms of dosing and which neurotransmitter it affects more strongly:
- Venlafaxine (Effexor XR): The oldest and most widely prescribed SNRI. At lower doses it acts mainly on serotonin; norepinephrine effects become more prominent at higher doses. Typical doses range from 75 to 225 mg daily, with a maximum of 375 mg.
- Duloxetine (Cymbalta): Affects both serotonin and norepinephrine more evenly from the start. Usual doses run 30 to 60 mg daily, up to a maximum of 120 mg. It’s the most commonly used SNRI for pain conditions.
- Desvenlafaxine (Pristiq): A metabolite of venlafaxine, meaning it’s the active compound your body naturally converts venlafaxine into. Most people take a flat 50 mg dose, which simplifies dosing. The maximum is 100 mg.
- Levomilnacipran (Fetzima): Has a stronger effect on norepinephrine relative to serotonin, which can be helpful for fatigue and low motivation alongside depression.
- Milnacipran (Savella): Approved only for fibromyalgia, not depression, in the U.S.
How SNRIs Differ From SSRIs
SSRIs (selective serotonin reuptake inhibitors) like sertraline and fluoxetine target only serotonin. SNRIs add norepinephrine to the equation. In practice, this dual action can matter in a few situations. If depression comes with significant fatigue, low motivation, or difficulty concentrating, the norepinephrine boost may help where serotonin alone falls short. SNRIs also have a clear advantage when depression or anxiety coexists with chronic pain, since the norepinephrine pathway is central to pain modulation in the spinal cord.
SSRIs are still typically tried first for straightforward depression or anxiety because they tend to have a somewhat milder side effect profile. SNRIs are a common next step when SSRIs haven’t provided enough relief, or when a pain component makes the dual mechanism more appealing from the start.
Common Side Effects
Because SNRIs raise levels of two neurotransmitters instead of one, their side effects overlap with SSRIs but also include some that are driven specifically by norepinephrine. The most frequently reported issues include nausea, dry mouth, dizziness, drowsiness or insomnia, constipation, and excessive sweating.
The norepinephrine-related effects deserve particular attention. Increased norepinephrine can accelerate heart rate and raise blood pressure, sometimes enough to require monitoring. This effect is best documented with venlafaxine, especially at higher doses. Blood pressure checks are recommended during the early weeks of treatment and whenever the dose is increased. For most people the change is modest, but anyone with existing high blood pressure or cardiovascular concerns should have this tracked closely.
Sexual side effects, including reduced desire and difficulty reaching orgasm, occur with SNRIs just as they do with SSRIs. These are driven primarily by the serotonin side of the medication. Most side effects are strongest in the first one to two weeks and gradually ease as your body adjusts.
Serotonin Syndrome Risk
The most serious drug interaction to know about involves combining an SNRI with another medication that also raises serotonin. This can trigger serotonin syndrome, a potentially life-threatening condition marked by agitation, rapid heartbeat, high body temperature, muscle twitching, and confusion. The highest risk comes from combining an SNRI with an older class of antidepressant called MAOIs. SNRIs and MAOIs should never be taken together, and there needs to be a washout period of at least two weeks between stopping one and starting the other.
Other serotonin-raising substances that can create problems include certain migraine medications (triptans), the supplement St. John’s wort, and some opioid painkillers. Always make sure any prescriber knows you’re taking an SNRI before starting a new medication.
Discontinuation and Tapering
SNRIs should not be stopped abruptly. Doing so can cause discontinuation syndrome, a cluster of uncomfortable symptoms that typically begins within a few days of missing doses or stopping suddenly. Common symptoms include dizziness, nausea, headaches, irritability, insomnia, and flu-like feelings.
One of the most distinctive symptoms is what patients call “brain zaps,” brief sensations that feel like small electric shocks in the head. These likely result from the nervous system struggling to adapt to a sudden drop in neurotransmitter levels. The neural networks that had adjusted to higher serotonin and norepinephrine essentially misfire as they recalibrate. Brain zaps are not dangerous, but they can be disorienting and unpleasant.
The standard approach is a gradual taper, reducing the dose in steps over several weeks. A slower taper generally means milder or no withdrawal symptoms. Venlafaxine has a reputation for being particularly difficult to discontinue, partly because its shorter duration in the body means levels drop quickly between doses. If symptoms become severe during a taper, restarting the medication at the previous dose and then reducing more slowly typically resolves the problem.
What to Expect When Starting an SNRI
Mood improvements from an SNRI generally take two to four weeks to become noticeable, and full benefits may not arrive for six to eight weeks. Side effects, unfortunately, often show up before the therapeutic effects do, which is why the first couple of weeks can feel discouraging. Nausea and jitteriness are common early on and usually fade. Starting at a lower dose and gradually increasing helps minimize this adjustment period.
For pain conditions, the timeline is similar. Some people notice pain relief within the first two weeks, but a full trial of six to eight weeks at an adequate dose is typically needed before deciding whether the medication is working. Because the effects of norepinephrine and serotonin reuptake inhibition are dose-dependent, your prescriber may need to adjust the dose more than once to find the right balance between benefit and tolerability.